IL1B and melanoma: Combined with further biochemical results, our metabolomic study suggests initial evidence for an ABCB5-dependent IL1β—mediated signaling pathway for the regulation of glycolysis in human melanoma cells, thus opening new avenues for future research projects elucidating additional mechanistic details.